Literature DB >> 21784901

Allelic variants of complement genes associated with dense deposit disease.

Maria Asuncion Abrera-Abeleda1, Carla Nishimura, Kathy Frees, Michael Jones, Tara Maga, Louis M Katz, Yuzhou Zhang, Richard J H Smith.   

Abstract

The alternative pathway of the complement cascade plays a role in the pathogenesis of dense deposit disease (DDD). Deficiency of complement factor H and mutations in CFH associate with the development of DDD, but it is unknown whether allelic variants in other complement genes also associate with this disease. We studied patients with DDD and identified previously unreported sequence alterations in several genes in addition to allelic variants and haplotypes common to patients with DDD. We found that the likelihood of developing DDD increases with the presence of two or more risk alleles in CFH and C3. To determine the functional consequence of this finding, we measured the activity of the alternative pathway in serum samples from phenotypically normal controls genotyped for variants in CFH and C3. Alternative pathway activity was higher in the presence of variants associated with DDD. Taken together, these data confirm that DDD is a complex genetic disease and may provide targets for the development of disease-specific therapies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784901      PMCID: PMC3148710          DOI: 10.1681/ASN.2010080795

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  60 in total

Review 1.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

2.  Prediction of deleterious human alleles.

Authors:  S Sunyaev; V Ramensky; I Koch; W Lathe; A S Kondrashov; P Bork
Journal:  Hum Mol Genet       Date:  2001-03-15       Impact factor: 6.150

3.  Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions.

Authors:  Lance W Hahn; Marylyn D Ritchie; Jason H Moore
Journal:  Bioinformatics       Date:  2003-02-12       Impact factor: 6.937

Review 4.  Structure and function of complement C5 convertase enzymes.

Authors:  M K Pangburn; N Rawal
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

5.  SIFT: Predicting amino acid changes that affect protein function.

Authors:  Pauline C Ng; Steven Henikoff
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

6.  SNPStats: a web tool for the analysis of association studies.

Authors:  Xavier Solé; Elisabet Guinó; Joan Valls; Raquel Iniesta; Víctor Moreno
Journal:  Bioinformatics       Date:  2006-05-23       Impact factor: 6.937

7.  Dense deposit disease associated with monoclonal gammopathy of undetermined significance.

Authors:  Sanjeev Sethi; William R Sukov; Yuzhou Zhang; Fernando C Fervenza; Donna J Lager; Dylan V Miller; Lynn D Cornell; Srivilliputtur G Santhana Krishnan; Richard J H Smith
Journal:  Am J Kidney Dis       Date:  2010-09-15       Impact factor: 8.860

8.  Anti-factor B autoantibody in dense deposit disease.

Authors:  Stefanie Strobel; Miriam Zimmering; Krisztián Papp; József Prechl; Mihály Józsi
Journal:  Mol Immunol       Date:  2010-03-01       Impact factor: 4.407

9.  Long PCR detection of the C4A null allele in B8-C4AQ0-C4B1-DR3.

Authors:  S F Grant; H Kristjánsdóttir; K Steinsson; T Blöndal; A Yuryev; K Stefansson; J R Gulcher
Journal:  J Immunol Methods       Date:  2000-10-20       Impact factor: 2.303

10.  A novel mutation in the complement factor B gene (CFB) and atypical hemolytic uremic syndrome.

Authors:  Hanan Tawadrous; Tara Maga; Josefina Sharma; Juan Kupferman; Richard J H Smith; Morris Schoeneman
Journal:  Pediatr Nephrol       Date:  2010-01-27       Impact factor: 3.714

View more
  45 in total

1.  Secondary focal and segmental glomerulosclerosis associated with single-nucleotide polymorphisms in the genes encoding complement factor H and C3.

Authors:  Sanjeev Sethi; Fernando C Fervenza; Yuzhou Zhang; Richard J H Smith
Journal:  Am J Kidney Dis       Date:  2012-05-16       Impact factor: 8.860

Review 2.  C3 Glomerulopathy.

Authors:  Magdalena Riedl; Paul Thorner; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-04-07       Impact factor: 3.714

Review 3.  Crescentic acute glomerulonephritis with isolated C3 deposition: a case report and review of literature.

Authors:  Song Mao; Xiaoyan Xuan; Yugen Sha; Sanlong Zhao; Aihua Zhang; Songming Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  C3 glomerulonephritis and autoimmune disease: more than a fortuitous association?

Authors:  Mariam P Alexander; Fernando C Fervenza; An S De Vriese; Richard J H Smith; Samih H Nasr; Lynn D Cornell; Loren P Herrera Hernandez; Yuzhou Zhang; Sanjeev Sethi
Journal:  J Nephrol       Date:  2015-07-18       Impact factor: 3.902

Review 5.  Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.

Authors:  Marina Noris; Roberta Donadelli; Giuseppe Remuzzi
Journal:  Pediatr Nephrol       Date:  2018-06-09       Impact factor: 3.714

6.  Systematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease.

Authors:  Xin Sheng; Chengxiang Qiu; Hongbo Liu; Caroline Gluck; Jesse Y Hsu; Jiang He; Chi-Yuan Hsu; Daohang Sha; Matthew R Weir; Tamara Isakova; Dominic Raj; Hernan Rincon-Choles; Harold I Feldman; Raymond Townsend; Hongzhe Li; Katalin Susztak
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-03       Impact factor: 11.205

7.  C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.

Authors:  Yuzhou Zhang; Nicole C Meyer; Fernando C Fervenza; Winnie Lau; Adam Keenan; Gabriel Cara-Fuentes; Dingwu Shao; Aalia Akber; Veronique Fremeaux-Bacchi; Sanjeev Sethi; Carla M Nester; Richard J H Smith
Journal:  Am J Kidney Dis       Date:  2017-08-24       Impact factor: 8.860

8.  Eculizumab therapy in a patient with dense-deposit disease associated with partial lipodystropy.

Authors:  Ozan Ozkaya; Hulya Nalcacioglu; Demet Tekcan; Gurkan Genc; Bilge Can Meydan; B Handan Ozdemir; M Kemal Baysal; Hasan Tahsin Keceligil
Journal:  Pediatr Nephrol       Date:  2014-01-26       Impact factor: 3.714

Review 9.  Treatment options for C3 glomerulopathy.

Authors:  Carla M Nester; Richard J Smith
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-03       Impact factor: 2.894

Review 10.  The Genetics of Ultra-Rare Renal Disease.

Authors:  Melissa Muff-Luett; Carla M Nester
Journal:  J Pediatr Genet       Date:  2016-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.